Trecator (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)


Welcome to the PulseAid listing for the Trecator drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This Antimycobacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
NON-PROPRIETARY NAME: ethionamide
SUBSTANCE NAME: ETHIONAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimycobacterial [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-11-08
END MARKETING DATE: 0000-00-00


Trecator HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTrecator from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
LABELER NAME: Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2004-11-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0008-4117_b4a80867-83e7-4ce0-8023-4f02c6765b90
PRODUCT NDC: 0008-4117
APPLICATION NUMBER: NDA013026

Other ETHIONAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.Trecator